Aspen Pharmacare
Aspen Pharmacare Holdings Limited, commonly known as Aspen, is a leading global pharmaceutical company headquartered in Durban, South Africa. Established in 1850, Aspen has grown to become a significant player in the healthcare industry, with a strong presence in regions such as Europe, Asia, and Latin America. The company focuses on the development, manufacturing, and marketing of a diverse range of pharmaceutical products, including anaesthetics, thrombosis, and oncology medications. Aspen is renowned for its commitment to quality and innovation, offering unique formulations and a robust portfolio of generic and branded medicines. With a strategic emphasis on expanding its global footprint, Aspen has achieved notable milestones, including the acquisition of several international businesses. Today, Aspen stands as a prominent force in the pharmaceutical sector, recognised for its dedication to improving patient outcomes worldwide.
DitchCarbon Score
How does Aspen Pharmacare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Aspen Pharmacare's score of 28 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Aspen Pharmacare's reported carbon emissions
In 2023, Aspen Pharmacare reported total carbon emissions of approximately 149,301,000 tonnes CO2e, comprising 37,424,000 tonnes from Scope 1 and 111,877,000 tonnes from Scope 2 emissions. Additionally, Scope 3 emissions included about 70,991,000 tonnes from waste generated in operations. Aspen Pharmacare has set an ambitious target to reduce its global carbon dioxide emissions by 45% by 2030, relative to 2010 levels. This commitment reflects the company's dedication to sustainability and aligns with industry standards for climate action. The company has actively participated in initiatives such as the UN Global Compact and the Climate Ambition Accelerator, demonstrating its commitment to addressing climate change and reducing its environmental impact across all scopes of emissions.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 10,917,000 | 00,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 114,615,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | 00,000,000 | - | - | - | - | - | - | - | 00,000,000 | 000,000 | 00,000,000 | - | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Aspen Pharmacare is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
